64 related articles for article (PubMed ID: 8469808)
1. [Thrombolytic therapy in acute myocardial infarct. New performance protocols. Their influence on mortality and the incidence of complications].
Torres Martínez G; Rodríguez García P; Galcerá Tomás J; Castillo Soria F; Cantón Martínez A; Palazón Sánchez C; Seller Pérez G
Rev Esp Cardiol; 1993 Apr; 46(4):235-41. PubMed ID: 8469808
[TBL] [Abstract][Full Text] [Related]
2. [Intracranial hemorrhage following thrombolytic therapy in acute myocardial infarct].
Torres Martínez G; Rodríguez García P; Cantón Martínez A; Castillo Soria F; Galcerá Tomás J; García Paredes T; Bru Cartagena M; Jara Pérez P
Rev Esp Cardiol; 1994 Feb; 47(2):73-80. PubMed ID: 8165351
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
[TBL] [Abstract][Full Text] [Related]
4. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
5. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
8. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
9. [Repeat thrombolysis in acute myocardial infarction].
Király C; Timár S
Orv Hetil; 2001 Apr; 142(13):665-9. PubMed ID: 11338569
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and hospital mortality of acute myocardial infarction in elderly patients treated with thrombolytic agents].
Pabón Osuna P; Bermeio García J; Arribas Jiménez A; Nieto Ballesteros F; Sáez Jiménez A; Martin Luengo C; Fernández Avilés F; de la Torre Carpete M; Garcimartín Cerrón I
Rev Esp Cardiol; 1996 Jul; 49(7):501-8. PubMed ID: 8754444
[TBL] [Abstract][Full Text] [Related]
11. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
[TBL] [Abstract][Full Text] [Related]
14. [A change in the prescription of thrombolytic treatment in elderly patients. The experience of the Hospital de León].
Alonso-Orcajo N; Franco Aranda C; García Calabozo R; Fidalgo Andrés ML; Rodríguez García MA; Bayón Fernández J; García Porrero E; Martínez-Sande JL; Simarro E
Rev Esp Cardiol; 1994 Nov; 47(11):741-6. PubMed ID: 7800904
[TBL] [Abstract][Full Text] [Related]
15. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
16. Thrombolysis for acute myocardial infarction: drug review.
Cundiff DK
MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
[TBL] [Abstract][Full Text] [Related]
17. [Thrombolysis in acute myocardial infarct in everyday clinical practice].
De Benedetti E; Urban P; Burgan S; Dorsaz PA; Chatelain P; Gaspoz JM; Chevrolet JC; Unger PF
Schweiz Med Wochenschr; 1997 Aug; 127(31-32):1285-90. PubMed ID: 9333939
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
